Mallinckrodt   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: St Louis MO United States (1867)
Status: Acquired by Avon Products (1982) → now International Minerals and Chemical Corporation (1986)

Organization Overview

First Clinical Trial
1998
NCT00005773
First Marketed Drug
1947
methadone (methadose)
First NDA Approval
1973
iocetamic acid (cholebrine)
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Mallinckrodt | MALLINCKRODT | MALLINCKRODT ARD | MALLINCKRODT HOSP | MALLINCKRODT INC | Mallinckrodt (v1) | Mallinckrodt (v2) | MALLINKRODT NUCLEAR